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sing Delayed-Enhancement Magnetic Resonance Imaging
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handra Bomma, MD,* Khurram Nasir, MBBS,* Boas Rosen, MD,* João A. C. Lima, MD,*
ugh Calkins, MD,* David A. Bluemke, MD, PHD*†
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OBJECTIVES We evaluated the role of myocardial delayed-enhancement (MDE) magnetic resonance
imaging (MRI) for noninvasive detection of fibrosis in Arrhythmogenic right ventricular
dysplasia/cardiomyopathy (ARVD/C).
BACKGROUND Arrhythmogenic right ventricular dysplasia/cardiomyopathy is characterized by fibro-fatty
replacement of the right ventricle (RV) leading to arrhythmias and RV failure. Endomyo-
cardial biopsy can demonstrate fibro-fatty replacement of the RV myocardium; however, the
test is invasive and carries a risk of perforation.
METHODS Thirty consecutive patients were prospectively evaluated for ARVD/C. Magnetic resonance
imaging was performed on a 1.5-T scanner. Ten minutes after intravenous administration of
0.2 mmol/kg of gadodiamide, MDE-MRI was obtained. Diagnosis of ARVD/C was based
upon the Task Force criteria and did not include MRI findings.
RESULTS Twelve (40%) of 30 patients met the Task Force criteria for ARVD/C. Eight (67%) of the
12 ARVD/C patients demonstrated increased signal on MDE-MRI in the RV compared
with none (0%) of the 18 patients without ARVD/C (p  0.001). Endomyocardial biopsy
was performed in 9 of the 12 ARVD/C patients. Of the nine patients, four had fibro-fatty
changes consistent with the diagnosis of ARVD/C. Each of these patients had increased RV
signal on MDE-MRI. None of the patients without ARVD/C had any abnormalities either
on histopathology or on MDE-MRI. Electrophysiologic testing revealed inducible sustained
ventricular tachycardia (VT) in six of the eight ARVD/C patients with delayed enhancement,
compared with none of the ARVD/C patients without delayed enhancement (p  0.01).
CONCLUSIONS Noninvasive detection of RV myocardial fibro-fatty changes in ARVD/C is possible by
MDE-MRI. Magnetic resonance imaging findings had an excellent correlation with
histopathology and predicted inducible VT on programmed electrical stimulation, suggesting
a possible role in evaluation and diagnosis of patients with suspected ARVD/C. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.09.053Cardiol 2005;45:98–103) © 2005 by the American College of Cardiology Foundation
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arrhythmogenic right ventricular dysplasia/cardiomyopathy
ARVD/C) is characterized by structural and functional
bnormalities of the right ventricular (RV) leading to
entricular arrhythmias and progressive RV failure. The
ost striking morphological feature of ARVD/C is diffuse
r segmental replacement of myocardium in the RV free
all by fibro-fatty tissue (1–3). Diagnosis of ARVD/C at its
arly stages remains a clinical challenge (4,5), more so in
atients with minimal RV abnormalities at echocardio-
raphic or angiographic examination. Endomyocardial bi-
psy has the potential for in vivo demonstration of typical
bro-fatty replacement of the RV myocardium. However,
ensitivity of this test is low because, for reasons of safety,
iopsy samples are usually taken from the septum, a region
ncommonly involved by the disease (6).
From the *Division of Cardiology and †Department of Radiology, The Johns
opkins University, Baltimore, Maryland. The Johns Hopkins ARVD program is
unded by a private grant from the Bogle Foundation and the National Institutes of
ealth Research Grant 1 UO1 HL65594-01A1.m
Manuscript received April 10, 2004; revised manuscript received September 17,
004, accepted September 21, 2004.Magnetic resonance imaging (MRI) is a promising tech-
ique for delineation of RV anatomy and function as well as
or characterizing the composition of the RV wall, especially
ith regard to the presence of fatty tissue (7,8). However,
at visualization on MRI has not been found to be specific
or ARVD (9,10), and there is poor inter-reader agreement
n reporting of fat (11). Recently, myocardial delayed
nhancement (MDE) after intravenous administration of a
adolinium-based contrast agent has been shown in dys-
unctional areas of the left ventricle in patients with prior
yocardial infarction and fibrous scar (12,13). We hypoth-
sized that the RV in ARVD/C patients will demonstrate
ncreased signal on MDE-MRI because of the fibrotic
ature of the disease process.
ETHODS
he study population included 30 patients who were pro-
pectively evaluated for possible ARVD/C because of either
family history or left bundle branch block (LBBB)
orphology ventricular arrhythmia. Each of these patients
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January 4, 2005:98–103 Noninvasive Imaging of Fibrosis in ARVDas evaluated with a detailed clinical history, physical
xamination, electrocardiogram (ECG), signal-averaged
CG, two-dimensional echocardiography, and contrast-
nhanced cardiac MRI. Invasive testing, including electro-
hysiologic (EP) testing, right ventriculography, and endo-
yocardial biopsy, was performed guided by the results of
oninvasive testing. Final diagnosis of ARVD/C was made
ndependently of the MRI findings. The results of delayed-
nhancement MRI were then correlated with the final
iagnoses and the results of endomyocardial biopsy. The
tudy was approved by our institutional review board, and
nformed consent was obtained from the study subjects.
RI protocol. The MRI examination was performed with
1.5-T MR imager (CV/I, General Electric Medical
ystems, Waukesha, Wisconsin) using a dedicated phased-
rray cardiac coil. Transaxial black blood images were
cquired using a double-inversion recovery (blood suppres-
ion) fast-spin echo sequence (time to repetition [TR]  1
-R interval, time to echo [TE]  5 ms, slice thickness 
mm, interslice gap  5 mm, and field of view [FOV] 
4 to 28 cm). Following this, the same sequence was
epeated with the chemical shift fat suppression manually
uned to the fat peak to generate fat-suppressed axial black
lood images. Bright blood cine imaging in the axial and
hort-axis planes was acquired by a steady-state, free-
recession pulse sequence (TR  3.5, TE  1.2 ms, flip
ngle 45°, slice thickness 8 mm, interslice gap 4 mm,
nd FOV  36 to 40 cm, 10 views per segment, 35 ms
emporal resolution per cine phase). After intravenous
dministration of an MRI contrast agent (0.2 mmol/kg of
adodiamide [Omniscan, Amersham Health, Princeton,
ew Jersey]), inversion recovery prepared breath-hold cine
radient-echo images were obtained 20 min after contrast
gent injection. Initially, three-dimensional inversion recov-
ry prepared breath-hold, fat-suppressed, gradient-echo im-
ging was performed in the short axis and axial planes. The
se of a variable sampling in time segmentation (14) scheme
nabled the acquisition of three-dimensional volumes in a
Abbreviations and Acronyms
ARVD/C  arrhythmogenic right ventricular dysplasia/
cardiomyopathy
CNR  contrast-to-noise ratio
ECG  electrocardiogram
EP  electrophysiologic
FOV  field of view
LBBB  left bundle branch block
MDE  myocardial delayed enhancement
MRI  magnetic resonance imaging
ROI  region of interest
RV  right ventricle
RVEDV  right ventricular end diastolic volume
RVEF  right ventricular ejection fraction
RVOT  right ventricular outflow tract
VT  ventricular tachycardiaingle 24-heartbeat breath-hold. For three-dimensional im- vging, the parameters were as follows: TR/TE 4.7 ms/1.7
s, flip angle  20°, slice thickness  5 to 7 mm, matrix 
56 160, half Fourier acquisition, 12 slices interpolated to
4, FOV  360  270 mm. A single three-dimensional
lab encompassed both ventricles. This was followed by
reath-hold two-dimensional imaging (7.2/3.2; inversion
ime optimized 150 to 200 ms; flip angle  25°; slice
hickness 8 mm; slice gap 2 mm; number of excitations
2; matrix  256  192; and FOV  360  270 mm).
he two-dimensional MDE MRI scans were obtained in
he short axis and axial planes at 10-mm intervals covering
he entire right and left ventricles.
mage analysis. The RV was divided into three levels in
he short-axis plane: basal, mid, and apical. Each of these
hree levels was further divided into three segments (supe-
ior, midwall, inferior), resulting in a nine-segment model
or the RV. Gadolinium enhancement was assessed in each
f these segments by observers who had no knowledge of
linical information, using the following scale: 0 none and
 presence of delayed enhancement. The segment scores
ere summed, yielding a range per patient of 0 (no
nhancement in any slice) to 9.
The contrast-to-noise ratio (CNR) of the RV free wall
as evaluated as follows: a region of interest (ROI) with a
ize of 0.1 to 0.2 cm2 was placed within the RV wall in the
one of increased signal intensity. A second ROI of iden-
ical size was placed within the nearest zone of the RV free
all showing normal-appearing myocardium. The differ-
nce between the mean signal intensities of both ROIs was
hen divided by the standard deviation of the background
oise signal (ROI  2 cm2) measured anteriorly to the RV.
Global ventricular volumes were calculated from the short-
xis cine images using a summation of disks method (“Simp-
on’s Rule”), with integration over the image slices using the
oftware program MASS (Medis, Leiden, The Netherlands).
ndomyocardial biopsy. Biopsy specimens were taken
rom the myocardial border of the interventricular septum,
ith the use of modified Stanford-Caves bioptome (Schol-
en Surgical, Redwood City, California), by way of the right
nternal jugular vein. At least five specimens were obtained
rom each patient, immediately fixed in 10% formalin,
mbedded in paraffin, sectioned, stained with hematoxylin
nd eosin, and reviewed at a minimum of four section levels
y one cardiac pathologist. The reviewing pathologist was
ot aware of the clinical characteristics of the patients. A
ercentage of fat 3% and of fibrous tissue 40% with
45% myocytes was considered diagnostic of ARVD/C (6).
P study protocol. A standardized EP study was per-
ormed in all patients. A conventional stimulation protocol
as used with one, two, and three extrastimuli delivered at
hree drive train cycle lengths at the RV apex and RV
utflow tract. Burst pacing at cycle lengths from 600 to 300
s was also used. Testing was performed in the baseline
tate and during a 2 /min infusion of isoproterenol. A
tudy was considered positive if sustained monomorphic
entricular tachycardia (VT) was induced (VT with uniform
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Noninvasive Imaging of Fibrosis in ARVD January 4, 2005:98–103RS configuration and cycle length200 ms lasting 30 s or
equiring termination because of hemodynamic compromise).
he EP study was negative if the stimulation protocol was
ompleted without induction of sustained VT. Induction of
on-sustained ventricular tachycardia (NSVT) and ventricular
brillation were considered nonspecific findings.
tatistical analyses. The data are presented as mean 
tandard deviation. The Mann-Whitney U test and Fisher
xact test was performed where appropriate. Spearman
orrelation coefficient was used for correlation analyses. A p
alue of 0.05 was considered statistically significant.
ESULTS
he mean age was 35  12 years, and 60% (18) of the
atients were female. Nine patients (30%) were evaluated
ecause of a family history of ARVD/C, and the others
resented with LBBB morphology VT (sustained [n  6]
nd nonsustained [n  15]). None of the patients had a
rior history of coronary artery disease, diabetes, or hyper-
ension. Coronary angiography performed in 14 (47%) of
he 30 patients upon discretion of their attending cardiolo-
ist revealed no significant coronary artery disease. Left
entricular function assessed on echocardiography was nor-
able 1. Clinical Characteristics of Patients With ARVD
Case
Age/
Gender
Family
History
ECG
Arrhy
T-Wave
Inversions SAECG
1 40/M No RBBB AB no
2 45/F No V1–V3 N SV
3 35/F Yes V1–V5 AB SV
4 16/M Yes V1–V5 N no
5 46/F No V1–V4 AB no
6 31/F No V1–V3 AB SV
7 31/F Yes V1–V4 N no
8 30/M No V1–V5 AB SV
9 21/F Yes V1–V4 N no
10 47/F Yes V1–V4 N no
11 23/M No V1–V4 AB SV
12 58/M No V1–V6 AB SV
RVD  arrhythmogenic right ventricular dysplasial cardiomyopathy; ECG  electr
S no symptoms; NSVT non-sustained ventricular tachycardia; PVC prematu
right ventricular dysfunction; SAECG signal-averaged electrocardiogram; severe
igure 1. (A) This panel shows an axial delayed enhanced image from an
ight ventricular (RV) myocardium is increased, similar to that of epicardial fat.
ulse sequence with chemical shift fat suppression. The enhanced RV anterio
ntensity (arrowhead). (C) This panel shows the same pulse sequence as pane
he signal-to-noise ratio is decreased compared with surface coil imaging in panels
onfirms that the RV signal is increased (arrows) because of increased myocardial sal in all patients. None of the patients had evidence of
ulmonary hypertension on Doppler echocardiography.
welve (40%) of the 30 patients met the Task Force criteria
nd were eventually diagnosed with ARVD/C. The clinical
haracteristics of the 12 patients with ARVD/C are shown
n Table 1. The remaining 18 patients had structurally
ormal hearts, and 12 of these were diagnosed with idio-
athic RV outflow tract tachycardia.
elayed-enhancement MRI. Figure 1A shows an exam-
le of delayed enhancement of the RV anterior wall on an
xial MDE-MRI from an ARVD/C patient. Epicardial fat
as hyperintense on a non-fat suppressed MDE-MRI, thus
aking it difficult to distinguish the enhanced RV myocar-
ial signal from that of epicardial fat. Signal in the anterior
hest wall close to the cardiac surface coil also contributed to
igh signal intensity in the anterior mediastinum. Using
hemical shift fat-suppression (Fig. 1B) and the body coil
nstead of the cardiac surface coil (Fig. 1C), the increased signal
ue to the epicardial fat and cardiac coil were eliminated, and
nhancement of the RV anterior wall was confirmed.
Eight of the 12 patients (67%) with a final diagnosis of
RVD/C demonstrated delayed enhancement with MDE-
RI compared with none (0%) of the 18 patients without
a Holter
RV Angiography
BiopsyRVD
Aneurysm/
Dyskinesia
NSVT severe anterior/RVOT fibro-fatty
SVT mild none fibro-fatty
ND severe anterior fibro-fatty
normal mild basal normal
NSVT none basal ND
11,000 PVCs mild none ND
350 PVCs mild none normal
ND mild RVOT normal
700 PVCs none normal normal
normal none basal ND
ND moderate anterior/RVOT myocarditis
ND severe basal fibrosis
gram; mild RVD  right ventricular ejection fraction 40% to 55%; ND  not done;
tricular contraction; RBBB right bundle branch block; RV right ventricle; RVD
 right ventricular ejection fraction35%; SVT sustained ventricular tachycardia.
thmogenic right ventricular dysplasia patient. The signal intensity of the
his panel shows the same level of the myocardium as panel A, using the same
is well-appreciated (arrows), and fat in the anterior chest wall has low signal
cept that body coil was used for signal transmission and reception. Althoughthmi
ne
T
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T
ocardioarrhy
(B) T
r wall
l B exA and B, the signal intensity is more uniform across the field of view. This
ignal rather than proximity to the phased array surface coil.
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January 4, 2005:98–103 Noninvasive Imaging of Fibrosis in ARVDhe diagnosis of ARVD/C (p 0.001). The CNR ratio was
ignificantly higher in the eight patients who had ARVD/C
ith delayed enhancement compared with the patients who
ad ARVD/C without enhancement, and the non-ARVD/C
atients (10.9  4, 1.5  3.6, and 0.8  2.9, respectively; p
0.01). The area of delayed enhancement also showed
yskinesis on cine imaging in six of the eight patients (75%).
In six of the eight ARVD/C patients with delayed
nhancement, the enhancement was seen in the basal
ub-tricuspid region, extending anteriorly into the RV
utflow tract. One patient had enhancement of entire
nterior wall and the apex; cine images in this patient
emonstrated multiple aneurysmal outpouchings of the RV.
he same patient also showed diffuse enhancement of the
V portion of the interventricular septum and of the lateral
all of the left ventricle (Fig. 2). A localized area of delayed
nhancement that correlated with a small bulging in the
utflow tract was observed in one asymptomatic patient
ith a family history of ARVD/C.
orrelation with endomyocardial biopsy. Endomyocar-
ial biopsy was performed in 9 of the 12 patients who had
he final diagnosis of ARVD/C. The remaining three
atients refused biopsy. Of these nine patients, four (44%)
ad fibro-fatty changes consistent with the diagnosis of
RVD/C, one (11%) had extensive myocarditis, and the
emainder (44%) had normal biopsies. Each of the four
atients with fibro-fatty changes on biopsy had delayed
nhancement on MDE-MRI. Of the four ARVD/C patients
ith normal biopsies, only one had delayed enhancement
imited to the antero-basal RV. Endomyocardial biopsy was
lso performed in 8 (44%) of the 18 patients who did not meet
he Task Force criteria for ARVD/C. None of these patients
igure 2. Four-chamber delayed enhanced image from a patient with
rrhythmogenic right ventricular dysplasia who had extensive lymphocytic
yocarditis on biopsy. The right ventricular (RV) wall and the RV portion
f the septum are diffusely enhanced. Further, there is a small area of
nhancement in the lateral wall of the left ventricle (LV), possibly
ndicating LV involvement.ad any abnormalities on histopathology. Also, none of these Aatients showed delayed enhancement on MDE-MRI. Pres-
nce of delayed enhancement in the RV showed an excellent
orrelation with fibrosis on biopsy (Fig. 3).
Patients who had delayed enhancement on MRI and who
ad positive biopsy results (n  4) had moderate-to-severe
V dysfunction (right ventricular ejection fraction [RVEF]
40%). Three patients with normal RVEF (55%) who
et ARVD/C Task Force criteria had negative biopsies,
nd one of them had delayed enhancement on MRI. This
uggested the possibility of a limited or concealed form of
RVD/C in these patients.
orrelation of delayed enhancement with EP findings. The
P testing was performed in 10 of the 12 ARVD/C patients;
had inducible sustained monomorphic VT, and 4 were
oninducible (Table 2). The six inducible patients showed
elayed enhancement of the RV, compared to only one of the
our ARVD/C patients who were noninducible (p 0.01). Of
he 18 non-ARVD/C patients, 12 had EP testing and none of
hem was inducible for sustained VT. Also, none of these
atients had delayed enhancement on MDE-MRI.
orrelation of delayed enhancement on MRI and RV
unction. The 30 patients were divided into three groups
ased on number of segments that showed delayed enhance-
ent (2 segments, 3 to 5 segments, and 5 segments), and
he right ventricular end-diastolic volume (RVEDV) and the
VEF were compared between the groups. The mean RVEF
ecreased (R2  0.82, p  0.02), while the mean RVEDV
howed a significant increase (R2  0.61, p 0.02) with
ncreasing extent of delayed enhancement (Figs. 4A and B).
ISCUSSION
yocardial delayed enhancement-magnetic resonance im-
ging is a new but well-validated technique for assessing
brosis following myocardial infarction (12,13). The iden-
ification of fibrosis using this method has not been previ-
usly described in ARVD/C. The presence of delayed
nhancement showed a high degree of correlation with endo-
yocardial biopsy and predicted induction of VT during EP
esting. Furthermore, there was a strong association between
he extent of delayed enhancement and RV dysfunction. These
ata suggest that MDE-MRI may have an important role in
he evaluation and diagnosis of ARVD/C.
Prior studies in ischemic and other nonischemic cardio-
yopathies have concluded that the mechanism of delayed
nhancement is nonspecific, but may be related to an
ncrease in volume distribution of gadolinium secondary to
nterstitial space expansion, which occurs in fibrous scarring
r inflammation. The histopathologic specimens obtained
n our patients with delayed enhancement showed predom-
nantly replacement fibrosis and fat infiltration in the
bsence of significant inflammation. Most frequently, de-
ayed enhancement was observed in the antero-basal region
nd in the RV outflow tract, consistent with the previously
escribed anatomic distribution of fibro-fatty infiltration in
RVD/C. In six of the eight ARVD/C patients, regional
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ion, suggesting lack of functioning myocardial cells in the
ame area. These observations lead us to conclude that the
ain mechanism of delayed enhancement in ARVD/C may
e localization of gadolinium to areas of fibrosis within the
V myocardium. Myocarditis may be yet another mecha-
ism of delayed enhancement in ARVD/C, as in the case of
ne patient who showed extensive myocarditis with minimal
nterstitial fibrosis.
igure 3. The top left and right panels represent the end-diastolic and en
n area of dyskinesia on right ventricular free wall characterizing a
elayed-enhanced MRI with increased signal intensity within the right ve
ight panel shows the corresponding endomyocardial biopsy. Trichrome sta
entricular muscle by adipose tissue. The adipose tissue cells (arrowhead)
eplacement fibrosis (arrow). There is no evidence of inflammation.
able 2. Correlation of MR Myocardial Delayed Enhancement W
ase
MR Imaging
Fat
Regional
Function MDE
Segments
Abnormal
A
M
1 ant/RVOT ant-DK ant 7 LBBB
2 none ant-DK ant 4 RBBB
3 ant/RVOT ant-DK diffuse 6 LBBB
4 basal normal none 0 nonind
5 basal basal DK basal 3 nonind
6 none RVOT DK none 0 not do
7 none normal none 0 nonind
8 ant/RVOT basal DK ant-basal 3 LBBB
9 none normal none 0 nonind
10 none ant-DK ant-basal 1 not do
11 ant/basal ant-DK ant/IVS* 8 LBBB
12 ant/RVOT ant-DK ant 7 RBBB
Involvement of LV lateral wall.
ant  RV anterior wall; DK  dyskinesis; EP  electrophysiologic; IA  inferior axis;
V  Left ventricular; MDE  myocardial delayed enhancement; RA  right axis; RVOMost cases of sustained monomorphic VT are associated
ith a myocardial scar. Re-entry during EP testing occurs
hrough surviving myocyte bundles in and around the
brotic areas, which are visualized as contrast-enhanced
reas on MDE-MRI. Turrini et al. (15) have previously
eported an association between fibrosis on endomyocardial
iopsy and the occurrence of sustained ventricular arrhyth-
ias in ARVD/C. Abnormal signal-averaged ECG and
educed RVEF were surrogates for extent of fibrosis in
olic frames of a short-axis cine magnetic resonance image (MRI) showing
ventricular aneurysm (arrows). The bottom left panel displays the
lar myocardium (arrows), at the location of RV aneurysms. The bottom
the right ventricle at high magnification shows marked replacement of the
egular in size and infiltrate the ventricular muscle. There is also abundant
EP and Histologic Findings in ARVD Patients
EP Testing Histopathology
hmia
ology Site
Length
(ms) Fat Fibrosis Inflammation
apex 260   none
apex 202   none
RVOT 240   
— — none none none
— — ND ND ND
— — ND ND ND
— — none none none
BBB-RA apex 240,232 none none none
— — none none 
— — ND ND ND
RVOT 230 none  
RVOT 300   d-syst
focal
ntricu
in ofith
rrhyt
orph
-SA
-LA
-IA
ucible
ucible
ne
ucible
-IA, L
ucible
ne
-SA
-LAIVS  interventricular septum; LA  left axis; LBBB  left bundle branch block;
T  right ventricular outflow tract.
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January 4, 2005:98–103 Noninvasive Imaging of Fibrosis in ARVDRVD/C. Consistent with their findings, each of the six
RVD/C patients who had inducible monomorphic VT on
P testing demonstrated myocardial delayed enhancement
f the RV. Myocardial delayed enhancement correlated
etter than abnormal signal-averaged ECG (5 of 6) or RV
ysfunction (4 of 6) in predicting VT on EP testing. None
f the ARVD/C patients without delayed enhancement was
nducible. The above finding highlights the potential of
DE-MRI not only to noninvasively visualize scar tissue,
ut also to predict the results of EP testing.
In our study, only two-thirds of the ARVD/C patients
howed delayed enhancement. The reason for the lack of
elayed enhancement in the remainder may be the presence
f a pure fatty form of ARVD/C, or may reflect the
nsensitivity of current MRI techniques to detect a small
mount of fibrosis in early disease.
tudy limitations. For reasons of safety, biopsy specimens
ere obtained from an endovascular approach. As such, the
iopsy specimens are representative of subendocardial his-
ology only. The location of the biopsies could not be
igure 4. (A) Correlation between the extent of delayed enhancement and
ight ventricular ejection fraction. (B) Correlation between the extent of
elayed enhancement and right ventricular end diastolic volume.ystematically correlated with the MRI findings on a one-o-one basis. The low yield of biopsy (44%) in our study may
n fact reflect sampling error or may also be due to the focal
ature of the disease process. Another important limitation of
ur study is the small sample size. Further studies with a large
ample size are needed to confirm our results.
linical implications. This study suggests for the first time
hat fibrosis of the RV in ARVD/C can be noninvasively
isualized using MRI. The presence of delayed enhancement
n ARVD/C was associated with inducibility during EP testing
nd may also be useful in risk stratification. Abnormal RV
nhancement on MRI may help improve the specificity of
RI for ARVD/C diagnosis. The absence of delayed en-
ancement in each of the patients with idiopathic VT is
eassuring, and consistent with the pathophysiology of ventric-
lar arrhythmias in this disease.
eprint requests and correspondence: Dr. David A. Bluemke,
RI Building, Room 143, Department of Radiology, The Johns
opkins Hospital, 600 N. Wolfe Street, Baltimore, Maryland
1287. E-mail: dbluemke@jhmi.edu.
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